GlassScriptPhysician profile
Matthew D Riscinti
NPI 1093101909
$24,634.21
in general payments reported to CMS, 2019-2025
4 companies · $57.68 in 2025
The $57.68 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,419 · 2020: $1,060 · 2021: $13K · 2022: $227 · 2023: $38.13 · 2024: $7,475 · 2025: $57.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,899 · Long Term Medical Supply Or Device Loan: $3,500 · Food and Beverage: $122 · Gift: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,899.00 |
| Long Term Medical Supply Or Device Loan | $3,500.00 |
| Food and Beverage | $122.06 |
| Gift | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Butterfly Network, INC. | $20,734.76 | 2019-2024 | |
| Exo Imaging, INC. | $3,550.00 | 2024 | Exo Iris |
| Ge Healthcare | $175.00 | 2022 | |
| Mindray Ds USA, INC. | $174.45 | 2022-2025 | Te7 Max, Te X |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Riscinti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.